chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Result: Positive /Nasal Swab; Result: Positive /Nasal Swab; This is a spontaneous report received from a non-contactable reporter(s) (Nurse).  A 31-year-old male patient received BNT162b2 (BNT162B2), on 21Dec2021 as dose 3 (booster), single (Lot number: FF2589) at the age of 31 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: DRUG INEFFECTIVE (medically significant) with onset 07Jun2022, outcome "unknown", COVID-19 (medically significant) with onset 07Jun2022, outcome "not recovered" and all described as "Result: Positive /Nasal Swab". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (06Jun2022) Negative, notes: Nasal Swab; (07Jun2022) Positive, notes: Nasal Swab.  Clinical course: The patient had trip returning 05Jun2022, then had HA fever congestion moderate 06Jun PM then + Ag test 07Jun am with high fever. It was unknown if the patient had Covid prior vaccination. Post vaccination the patient was tested with Covid-19.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: As there is limited information in the case provided, the causal association between the reported events and the suspect drug BNT162B2 cannot be excluded. The case will be reassessed once new information is available.   The impact of this report on the benefit/risk profile of the Pfizer drug is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
9 days after receiving injection pt developed 8 x 8 cm redness, tenderness Induration below the injection site (L) deltoid
it was noted that the vaccine was expired on 7/13/2022 and given on 7/15/2022 no adverse reaction reported as of today 7/26/2022
5 months after first immunization, I began experiencing hand and foot joint pain. In December 2021, I was diagnosed with beginning stage Rheumatoid Arthritis. I've seen research indicating that the immunizations could cause flares of autoimmune disorders and it makes me wonder if there's a connection between my immunizations and my diagnosis.
Low grade fever (100-101); chills; body aches; muscle ache; This is a spontaneous report received from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247) via an unspecified route of administration in the left arm on 23Mar2021 at 12:00 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. No medical history was reported. The patient did not have any allergies to medications, food or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications within 2 weeks of vaccination The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL3247) via an unspecified route of administration in the left arm on 02Mar2021 at 14:00 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. On 24Mar2021, the body temperature was measured and was found to be 100-101 (unspecified unit). On 24Mar2021, the patient experienced low grade fever (100-101), chills, body and muscle aches, approx. 12- 24 hours after second dose of vaccination. The events did not result in doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Treatment was not taken for the reported events. The clinical outcome of the events low grade fever (100-101), chills, body and muscle aches were resolved on an unknown date in Mar2021.   No follow-up attempts possible. No further information expected.
No other AE/PQC reported; received the Proquad and Varivax injection on the same day; This spontaneous report was received from a nurse and refers to a 12-month-old female patient. No information regarding the patient's medical history, concurrent conditions, concomitant medications and previous drug reactions or allergies was reported.  On 12-NOV-2020, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) for prophylaxis (lot number T016991 was verified to be valid, expiration date reported and established as 11-NOV-2021) (strength, dose, frequency and route of administration were not provided. On the same day, the patient was also vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) for prophylaxis (lot number T003707 was verified to be valid, expiration date reported and established as 30-JAN-2022) (strength, dose, frequency and route of administration were not provided.   The patient did not experience any additional adverse reactions.  This is one of two cases received from the same reporter.; Sender's Comments:  US-009507513-2011USA009469:
I experienced the shingles virus after my Moderna vaccine, resulting in an ear infection. I saw my doctor who prescribed two antibiotics and Gabapentin medication, which I am still on. My ear is not cleared up yet, I still have some opening to do.  Also for about 4 hours, I had very severe dizziness, I had to lie down, nausea to the point I could not get up.  As for today I am still have my ear infection but no nausea or dizziness.
The night following the vaccine, I experienced a fever above 100 degrees, with moderate chills, body aches, and joint pain.  The injection site was swollen and red in addition to general muscle pain from the shot.  This continued until about 48 hours after the vaccination.
pain on her heal; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program. The reporter is the patient.  A 72 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) at the age of 72 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Arthritis" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Cortisone for swelling. The following information was reported: PAIN (non-serious) with onset May2021, outcome "unknown", described as "pain on her heal".  Additional information: Patient has a condition in her foot heal  (before getting Pfizer Vaccine), like an arthritis condition that causes inflammation and she usually receives a shot of cortisone to reduce the swelling.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Information has been received from a nurse concerning a 57 year old white female (previously reported as 72 year old female) with asthma and no history of adverse drug reactions or allergies. On Dec 14 2005, the patient was vaccinated intramuscularly with a 0.5ml dose of Pneumococcal 23v polysaccharide vaccine (lot 651318/1006P). Concomitant therapy included levothyroxine (Levoxyl), pirbuterol acetate (Maxair), fluticasone propionate + salmeterol xinafoate (Advair) and bupropion HCL (Wellbutrin). On Dec 15 2005 the patient developed redness, swelling, warmth and pain at injection site. The patient contacted the physician and was recommended to rest. There were no other treatments. The patient did not undergo any lab diagnostic studies. It was reported that the patient was improving without treatment. At the time of this report, the patient was recovering from the events. Follow up information from the physician indicated that on Dec 14 2005 the patient developed a severe local reaction with arm swelling two times normal and a temperature 100C orally. The patient required 1.5 days of bedrest. Subsequently on Dec 17 2005 the patient recovered. The patients events were considered to be disabling by the physician. Additional information has been requested.
pt recv vax & mom states pt had pain immed p/inj & progressed;no resolution w/APAP by 19OCT96 swelling & pain was from shoulder to elbow;PMD gave ATB for general principals;
Redness, swelling, pain, low grade fever within 24 hr. -> pt. was evaluated in ER, diagnosed with "cellulitis" and treated with clindamycin P.O.
Covid-19; This spontaneous case was reported by a nurse and describes the occurrence of COVID-19 (Covid-19) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021, the patient experienced COVID-19 (Covid-19). At the time of the report, COVID-19 (Covid-19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Mar-2021, COVID-19: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications details not provided. Treatment information not provided.
the reaction was after the 2nd dose: fever (2 days),  body ache, weakness, loss of appetite, headache, muscle pain, shivers, red itching rashes.  The rash reaction was getting worse, allergy medicine (cetirizine) didn't work, went to Urgent care on 3rd day after vaccination since my rashes were getting all over my body and inside my mouth. was prescribed prednisolone. it helped me to get better
From initial information received on 02Sep04 from a health care professional, it was reported that a 22 year old female pt received her sixth dose of TD ADS Adult vaccine, lot number U1282AA, administered IM in an unspecified site and her first dose of YF Vax vaccine, lot number UE180A, administered SC in an unspecified site at 1:00PM on 30Aug04. Two days later, on 01Sep04, the pt developed flu-like symptoms, became lethargic and her left axilla lymph nodes became enlarged. On 02Sep04 the pt was examined by a physician and no enlargement of lymph nodes were noted.  The pt recovered status is currently unk. From additional information received on 28Sep04 from a health care professional, it was reported that the pt's flu like symptoms consisted of diarrhea, stomach cramping, and fatigue. She also had arm aches. It was not reported whether the pt recovered from these events.
Due to a miscommunication on my part, the MA was instructed to administer an adult flu vaccine instead of a vaccine program (I mistakenly thought that as she was over the age of 18, we could administer the adult vaccine). Patient tolerated the vaccine well and had no reaction of any sort. Both parents were with her the whole time.
This is a spontaneous report from a non-contactable other health care professional (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE Solution for injection), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as 1st dose, single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient, a physician assistant, reported that 4 hours after receiving the 1st dose of the BNT162B2 vaccine, she experienced a burning sensation in the interior aspect of her leg, then her thigh. Then, 36 hours later, she started to experience the burning sensation on her arms, neck, and face. The patient wanted to know if this was a normal reaction to the vaccine. The patient also wanted to know if she can take BENADRYL to treat the side effects. The outcome of the events was unknown. No follow-up attempts are possible, information about batch number cannot be obtained.
This spontaneous report as received from a certified medical assistant, refers to an unspecified number of patients of unknown age and gender. On an unknown dates, the patients were vaccinated with improperly stored ROTATEQ lot# K016261, expiration date: 23-JUN-2016, route defaulted to oral, dose was not reported. No adverse effects reported. This is one of several reports received from the same source. Additional information has been requested.
High fever 103.5 Bad aches/pains in joints Elevated B/P 176/98 Weakness in legs Loss of focus in Rt eye Self treating with Acetomenaphin. As of 7 pm 3/31 able to get temp down to 102.5. Taking 1000mg@5 hrs.  I called doctor but  no call back. Will continue  treatment and hope to get better.
patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. It was reported that there had been no power outages that would have impacted the Moderna vaccine. However, the reporter reiterates that because her facility was unable to download the digital data logger, they would need to treat this issue as a temperature excursion. The data logger was unable to download for the months of Dec 2021, Jan 2022, and Feb 2022. It was reported that the patients have been administered doses while the temperature excursion assessment was ongoing and reported that no adverse reactions were reported by any patients. Treatment medication was not provided by the reporter.
Exactly 3 minutes post vaccine administration, I was sitting in the observation area ?the right side of my face started tingling (pins & needles feel), HR went to high 120?s.  The staff in that area recognized I was not feeling right, they brought me water and oral Benadryl 25mg and Pepcid  20mg .  I sat for approx 30min.  My throat started feeling funny?scratchy and like I had a lump in my throat.  I kept feeling like I needed to clear throat .  At this time at staff took me to a monitored bed in PICU.  They gave me another 25mg of Benadryl.  Vital signs were stable after approx an hour.  I was discharged to family.
No sense of taste, tongue numb, fever, severe headaches, tired, ringing in ears, trouble swallowing, chewing, slurred speech, can't sleep, left eye blurry, pain in joints. 1-3 days after vaccine then symptoms got worse the next 2 weeks. Symptoms - eye drooped, mouth slanted, speech slurred, tongue numb, tired, insomnia, trouble swallowing, trouble chewing, pain behind ear, headache, eye wouldn't shut, eye blurry, no sense for taste, fever and chills, pain in joints, couldn't see to drive, missed work (works on computers).
My breathing pattern has change where I have moments that I can't breathe well; Headaches; This is a spontaneous report from a contactable consumer (patient). A 29-year-old female patient (not pregnant) received the first dose of BNT162B2 via an unspecified route of administration on the left arm on 29Jul2021 at 14:00 at the age of 29-year-old as single dose for COVID-19 immunization. Medical history was not reported. No COVID prior vaccination. No COVID tested post vaccination. No known allergy. No other vaccine in four weeks. No other medications in two weeks. On 31Jul2021 at 12:00 PM, the patient experienced breathing pattern had change where he had moments that he can't breathe well and headaches occur. No treatment was received. The outcome of events was not recovered.  Information about the Lot/batch number has been requested.
Day after 2nd dose vaccination (14Feb2021): slight dizziness, chills, flu-like symptoms.Very tired and required rest. Symptoms lasted approximately 1 day.; Day after 2nd dose vaccination (14Feb2021): slight dizziness, chills, flu-like symptoms.Very tired and required rest. Symptoms lasted approximately 1 day.; Day after 2nd dose vaccination (14Feb2021): slight dizziness, chills, flu-like symptoms.Very tired and required rest. Symptoms lasted approximately 1 day.; Day after 2nd dose vaccination (14Feb2021): slight dizziness, chills, flu-like symptoms.Very tired and required rest. Symptoms lasted approximately 1 day.; This is a spontaneous report from a contactable consumer. A 72-year-old non pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: unknown), via an unspecified route of administration, administered in right arm on 13Feb2021 (age at vaccination was 72 years) as dose 2, single for COVID-19 immunisation. It was unknown wheatear patient was received other vaccine in four weeks. The patient was currently a non-smoker, but history as a smoker. Other details were reported as unknown. Known allergies were unknown. Concomitant medication were not reported. Historical vaccine includes first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) administered in right arm on 22Jan2021 (age at vaccination was 72 years) dose 1, single for COVID-19 immunisation. The day after second dose vaccination, on 14Feb2021, the patient experienced slight dizziness, chills, flu like symptoms, very tired and required rest. Symptoms lasted approximately 1 day. No treatment received for adverse event. No COVID prior vaccination and patient was not COVID tested post vaccination. Outcome of the events was recovered on an unspecified date in 2021.  Information on the lot/batch number has been requested. Follow-up attempts completed. No further information expected.
This patient developed the onset of forearm swelling and redness 1 week (onset 1/28/2021) after receiving COVID-19 vaccine. There was no redness induration or other findings at the immunization site, all findings were distal to the elbow, and they included a very mild erythematous streak from the antecubital fossa to the wrist as well as mild to moderate edema on the volar aspect of the forearm. The symptoms were improving with Tylenol and application of topical Aspercreme at the patient had started prior to my evaluation on 2/1/2021.I could not explain the relationship to her vaccination, but felt it necessary due to the timing and fact it was in the same extremity as the immunization was given that I should report this
Client received her 1st dose of Moderna at 1536, and was asked to be in observation for 30 minutes. At 1603, she stated feeling pressure in her chest, having a headache on the right side of her head, and chills on the back of her neck. On a scale of 1-5, she said 3. Her BP @ 1604 was 132/88, @ 1633 was 124/90. She stated, the pain had diminished, felt better and was released at 1640.
get sick; Initial information received on 02-Dec-2020 regarding an unsolicited valid non-serious case received social media case through global digital media reported by a consumer (patient).  This case involves patient (unknown demographics) who got sick (illness), while the patient received vaccine influenza vaccine.  The patient's medical history, past medical treatment(s), vaccination(s) and family history were not provided.   Concomitant medications were not reported.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer) [lot number, expiry date and other dosing details were not reported] for prophylactic vaccination.  On an unknown date, (latency unknown) after initiation of suspect vaccine, it happened to patient every time I get one that's why I did not take them and I did not get sick (illness) and I could also be by someone with with the flu and not catch it  No relevant laboratory data was reported.  It was unknown if the patient received a corrective treatment. The events outcome was unknown.  Author/Reporter comment:  Product Name: Product name was not provided. Since this is a public post on the Sanofi flu shot campaign The Race to 200M we are assuming the consumer is referring to the Sanofi flu vaccine.  There will be no information available on the batch number for this case.
Pain at site of injection, nausea, body chills and body aches and headaches and sinus headaches.
*COVID-19 Vaccine dose #2 was given on 4/16/21 **TDAP booster was given on 3/10/21  I had no side effects after any of the vaccinations. I had a bit of a sore arm after the TDAP and the first COVID-19 vaccination but that was it. I didn't even have a sore arm really at all after the second COVID-19 shot. I did have a bandaid mark that lingered for a few days after the second COVID-19 shot but that was it.  I was 30 weeks and 6 days pregnant during the first COVID-19 shot. I felt the baby kicking normally after that and had normal follow up appointments after that too. My entire pregnancy was completely normal (this was my first pregnancy) with no complications or issues. I felt great throughout the entire pregnancy and was active biking, working out, walking, etc. I would consider myself a very healthy and active person and I followed all of the pregnancy "guidelines" in terms of what to eat, what not to eat, etc.  The adverse event here is the fact that my baby was stillborn at 39 weeks and 4 days. The appointment with the doctor the week before was totally normal too. What the doctor *thinks* happened is that my amniotic fluid somehow disappeared in the final few days before going into labor (they don't know where it went - my water did not break prior to the delivery of the baby) and the lack of fluid caused the baby to pass meconium. The high level of meconium surrounding her and the amount of time she was exposed to it seem to have degraded the umbilical cord, affecting her oxygen flow. By the time I went into labor, she may have already been dead, though I did not know it. When I got to the hospital in labor, there was already no heartbeat.  Baby delivery date: 5/26/21 Weight: 6 lbs 9 oz Length: 21 in  The mystery here is why was there suddenly a lack of fluid and why did that cause her to pass so much meconium? The doctors do not know and there does not seem to be a way to share this information with other doctors or facilities to gain a better understanding.
inconsolable crying for 1 hr-4 hrs p/vax given; given APAP 15 mins p/onset of crying; abrupt stop 45mins followed by several quiet mins of staring; no sz activity then returned to nl;
Has MS, had worsening weakness, admitted for worsening symptoms of MS. Fever 102